Big-cap biotech Alexion Pharmaceuticals (ALXN) won FDA approval Tuesday for rare-disease drug Kanuma, representing its third-ever drug approval. Kanuma was approved for lysosomal acid lipase deficiency (LAL-D), a genetic condition that brings serious organ damage and premature death. It’s very rare — the more severe form, known as Wolman disease, occurs in only one or two infants per million births, while the milder form, known as cholesteryl
Three out of four homes in America have a broadband Internet connection, but there is a wide gap between the highest and lowest metropolitan areas. Despite the Internet’s role in promoting economic prosperity, broadband adoption remains highly uneven among specific groups, limiting opportunity for many people, according to a new report by the Metropolitan Policy Program at the Brookings Institution. Silicon Valley, anchored by the city of San Jose
AT&T (T) is well on its way to acquiring content rights for mobile entertainment services following its purchase of DirecTV Group, and the company plans to offer both “big bundle” and “value-conscious” products targeting different types of consumers, its CEO Randall Stephenson said at a UBS conference on Tuesday. AT&T plans to disclose more details about the new wireless and video packages in January, Stephenson said. Some products could target